Mette M Rosenkilde

Mette M Rosenkilde has worked in various roles since 1999. Mette M began their career as an Assistant Professor, then Associate Professor, and finally Professor in Basic and Translational Pharmacology at the Faculty of Health and Medical Sciences, UCPH. In 2003, they became a Consultant for 7TM Pharma. In 2007, they were a Professor for Dansk Selskab for Farmakologi and Co-founder of INAGEN. In 2017, they were Co-Founder of Antag Therapeutics and Member of the Board of Directors & Co-Founder for Synklino and Bainan Biotech. In 2020, they became a Member of the Board of Directors for Independent Research Fund Denmark.

Mette M Rosenkilde attended Tjørnegårdsskolen for primary school, followed by Aurehøj gymnasium for high school. Mette M then obtained their Doctor of Medicine - MD from Københavns Universitet - University of Copenhagen in 1996 and their PhD in Molecular Pharmacology from the same university in 2000. In 2020, they obtained a Board Certificate from Board Company.